Latest Breaking News On - Ruxandra lenz - Page 4 : vimarsana.com

EQS-News: SphingoTec GmbH: Liberation from renal replacement therapy and early initiation to be supported by the kidney function biomarker Proenkephalin A 119-159 (penKid)

Issuer: SphingoTec GmbH / Key word(s): Study results/Research Update Liberation from renal replacement therapy and early initiation to be supported by the kidney function biomarker Proenkephalin

Pickkersp proenkephalinDeborah bergmannKostenloser wertpapierhandelClin biochemSphingotec gmbhSphingotec gmbRuxandra lenzDistribution servicesResearch updateScare medTec gmbhCorporate newsRegulatory announcements

EQS-News: SphingoTec GmbH: Boditech Med and SphingoTec close global licensing agreement for kidney function biomarker Proenkephalin A 119-159 (penKid)

Issuer: SphingoTec GmbH / Key word(s): Agreement/Contract Boditech Med and SphingoTec close global licensing agreement for kidney function biomarker Proenkephalin A 119-159 (penKid) 15.11.2022

Kangwon doSouth koreaRepublic of koreaKostenloser wertpapierhandelSphingotec gmbhEui yul choiSphingotec gmbRuxandra lenzBoditech med incClin chem labDistribution servicesYul choiBoditech medRev dis primersEarly biomarkerSeptic acute kidney injury

Boditech Med and SphingoTec Close Global Licensing Agreement for Kidney Function Biomarker Proenkephalin A 119-159 (penKid)

Boditech Med and SphingoTec Close Global Licensing Agreement for Kidney Function Biomarker Proenkephalin A 119-159 (penKid)
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

South koreaKangwon doRepublic of koreaSphingotec gmbh hennigsdorfSphingotec gmbhEui yul choiSphingotec gmbRuxandra lenzBoditech med incClin chem labBoditech medYul choiEarly biomarkerSeptic acute kidney injurySeptic shockChem lab

SphingoTec GmbH: Boditech Med and SphingoTec Close Global Licensing Agreement for Kidney Function Biomarker Proenkephalin A 119-159

Worldwide licensing agreement signed to develop and offer penKid as test on Boditech's fully automated immunoassay systems.The biomarker penKid adds diagnostic value and addresses current unmet needs in

Kangwon doSouth koreaRepublic of koreaKostenloser wertpapierhandelSphingotec gmbhSphingotec gmbhviewEui yul choiSphingotec gmbRuxandra lenzBoditech med incClin chem labBoditech medYul choiEarly biomarkerSeptic acute kidney injurySeptic shock

SphingoTec GmbH: Biomarker-Guided Trial Led by University Hospital Hamburg-Eppendorf Opens New Avenues for Personalized Medicine in COVID-19

A multi-center study led by UKE is evaluating one of the first personalized approaches for moderate to severe COVID-19 patients.The innovative biomarkers bio-ADM and DPP3 are guiding the enrollment of

San diegoUnited statesBioactive adrenomedullinAndreas bergmannKostenloser wertpapierhandelSphingotec gmbhSphingotec gmbRuxandra lenzPharmaceuticals gmbNexus dx incMahir karakas department of intensive care medicineIntensive care medicineCritically ill patientsEndothelial dysfunctionEight extreme critically ill patientsAnti adrenomedullin antibody adrecizumab